Efficacy and Safety of Neoadjuvant Pembrolizumab in III-IVA Resectable Oral Squamous Cell Carcinoma
- Status
- UNKNOWN
- Phase
- N/A
Clinical Trials Related to Pembrolizumab
Related studies linked through entity extraction aliases.
A Study of TBio-4101 (TIL) and Pembrolizumab in Patients With Advanced Solid Tumors
- Status
- TERMINATED
- Phase
- PHASE1
A Safety, Tolerability and Efficacy Study of NC410 Plus Pembrolizumab in Participants with Advanced Unresectable or Metastatic Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1/PHASE2
SX-682 With Pembrolizumab for the Treatment of Metastatic or Recurrent Stage IIIC or IV Non-Small Cell Lung Cancer
- Status
- RECRUITING
- Phase
- PHASE2
Pembro With Radiation With or Without Olaparib
- Status
- RECRUITING
- Phase
- PHASE2
CISH Inactivated TILs in the Treatment of NSCLC
- Status
- WITHDRAWN
- Phase
- PHASE1/PHASE2
A Platform Study of Novel Immunotherapy Combinations in Participants With Previously Untreated, Advanced/Metastatic Non-Small-Cell Lung Cancer
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Pembrolizumab, Carboplatin and Cabazitaxel in Aggressive Metastatic Castration Resistant Prostate Cancer (PEAPOD_FOS)
- Status
- RECRUITING
- Phase
- PHASE2
A Substudy of Investigational Agents in Programmed Cell Death-1/Ligand 1 (PD-1/L1) Refractory Locally Advanced or Metastatic Urothelial Carcinoma (mUC) (MK-3475-04A)
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
BXCL701 and Pembrolizumab in Patients With Metastatic Pancreatic Ductal Adenocarcinoma
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE2
Datopotamab Deruxtecan (Dato-DXd) and Pembrolizumab With or Without Platinum Chemotherapy in 1L Non-Small Cell Lung Cancer (TROPION-Lung07)
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE3
Induction Immunochemotherapy in Stage III-IVa Head and Neck Cancer
- Status
- UNKNOWN
- Phase
- PHASE2
Efficacy and Safety Study of OMTX705, Monotherapy and Anti-PD-1-combined, in Subjects With Advanced Solid Tumors.
- Status
- RECRUITING
- Phase
- PHASE1
Neoadjuvant Pembrolizumab and Lenvatinib for Mucosal Melanoma
- Status
- WITHDRAWN
- Phase
- PHASE2
A Study of Safety and Efficacy of KFA115 Alone and in Combo With Pembrolizumab in Patients With Select Advanced Cancers
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Pembrolizumab Plus CRT Followed by Surgery in Upper ESCC
- Status
- UNKNOWN
- Phase
- PHASE1/PHASE2
Dendritic Cell-Based Treatment Plus Immunotherapy for the Treatment of Metastatic or Unresectable Triple Negative Breast Cancer
- Status
- WITHDRAWN
- Phase
- PHASE2
A First-in-human Study to Learn How Safe the Study Drug BAY3375968, an Anti-CCR8 Antibody, is, When Given Alone or in Combination With Pembrolizumab, How it Affects the Body, How it Moves Into, Through, and Out of the Body, and to Find the Best Dose in Participants With Advanced Solid Tumors
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- PHASE1
Study of mRNA-4359 Administered Alone and in Combination With Immune Checkpoint Blockade in Participants With Advanced Solid Tumors
- Status
- RECRUITING
- Phase
- PHASE1/PHASE2
Olaparib in Combination With Pembrolizumab for Advanced Uveal Melanoma
- Status
- RECRUITING
- Phase
- PHASE2